| (1) |
Tunbridge W, Evered D, Hall R 1977 The spectrum
of thyroid disease in a community: the Whickham survey. Clin Endocrinol
7: 481-493. |
| (2) |
Klein I, Ojamaa K 2001 Thyroid hormone and the
cardiovascular system. N Engl J Med 344: 501-509. |
| (3) |
Franklyn J, Maisonneuve P, Sheppard M, Betteridge
J, Boyle P 1998 Mortality after treatment of hyperthyroidism with radioactive
iodine. N Engl J Med 338: 712-718. |
| (4) |
Goldman MB, Maloof F, Monson RR, Aschengrau A, Cooper
DS, Ridgway EC 1988 Radioactive iodine therapy and breast cancer. A
follow-up study of hyperthyroid women. Am J Epidemiol 127: 969-980. |
| (5) |
Hall P, Lundell G, Holm LE 1993 Mortality in
patients treated for hyperthyroidism with iodine-131. Acta Endocrinol 128:
230-234. |
| (6) |
Peters A, Ehlers M, Blank B, Exler D, Falk C, Kohlmann T, Fruehwald-Schultes
B, Wellhoener P, Kerner W, Fehm HL 2000 Excess triiodothyronine as a
risk factor of coronary events. Arch Intern Med 160: 1993-1999. |
| (7) |
Parle J, Maisonneuve P, Sheppard M, Boyle P, Franklyn
J 2001 A single low serum thyrotrophin (TSH) concentration predicts
increased all-cause and cardiovascular mortality in older persons in the
community: a 10-year cohort study. Lancet 358: 861-865. |
| (8) |
Peterson P, Hansen J 1988 Stroke in thyrotoxicosis with atrial
fibrillation. Stroke 19: 15-18. |
| (9) |
Sawin C, Geller A, Wolf P, Belanger AJ, Baker E,
Bacharach P, Wilson PW, Benjamin EJ, D’Agostino RB 1994 Low serum thyrotropin
concentrations as a risk factor for atrial fibrillation in older persons.
N Engl J Med 331: 1249-1252. |
| (10) |
Bar Sela S, Ehrenfeld M, EliakimM 1981 Arterial embolism in thyrotoxicosis
with atrial fibrillation. Arch Intern Med 141: 1191-1192. |
| (11) |
Bagchi N, Brown T, Parish R 1990 Thyroid dysfunction
in adults over age 55 years. A study in an urban US community. Arch Intern
Med 150: 785-787. |
| (12) |
Parle J, Franklyn J, Cross K, Jones C 1991 Prevalence
and follow-up of abnormal thyrotropin concentrations in the elderly in the
United Kingdom. Clin Endocrinol 34: 77-83. |
| (13) |
ToftAD 2001 Clinical practice. Subclinical hyperthyroidism.
[Review] [35 refs]. N Engl J Med 345: 512-516. |
| (14) |
Koutras D 1999 Subclinical hyperthyroidism. Thyroid
9: 311-315. |
| (15) |
Haissaguerre M, Jais P, Shah D, Takahashi A, Hocini
M, Quiniou G, Garrigue S, Le Mouroux A, Le Metayer P, Clementy J 1998
Spontaneous initiation of atrial fibrillation by ectopic beats originating
in the pulmonary veins. N Engl J Med 339: 659-666. |
| (16) |
Von Olshausen K, Bischoff S, Kahaly G, Mohr-Kahaly S, Erbel R, Beyer
J, Meyer J 1989 Cardiac arrhythmias and heart rate in hyperthyroidism.
Am J Cardiol 63: 930-933. |
| (17) |
Osman F, Daykin J, Sheppard M, Franklyn J, Gammage
M 2000 Cardiac rhythm abnormalities in thyrotoxicosis-the explanation
for excess vascular mortality. J Endocrinol 164: P321. |
| (18) |
Polikar R, Burger AG, Scherrer U, Nicod P 1993 The thyroid and
the heart. [Review] [97 refs]. Circulation 87:1435-1441. |
| (19) |
Vanderpump M, Ahlquist J, Franklyn J, Clayton R
1996 Consensus statement for good practice and audit measures in the management
of hypothyroidism and hyperthyroidism. BMJ 313: 539-544. |
| (20) |
Presti C, Hart R 1989 Thyrotoxicosis, atrial
fibrillation, and embolism, revisited. Am Heart J 117: 976-977. |
| (21) |
Miller V, Pearce L, Feinberg W, Rothrock J, Anderson
D, Hart R 1996 Differential effect of aspirin versus warfarin on clinical
stroke types in patients with atrial fibrillation. Neurology 46: 238-240. |
| (22) |
Nakazawa H, Sakuri K, Hamada N, Momotani N, Ito K 1982 Management
of atrial fibrillation in post-thyrotoxic state. Am J Med 72: 903-906. |
| (23) |
Dillmann W 1990 Biochemical basis of thyroid
hormone action in the heart. Am J Med 88: 626-630. |
| (24) |
Kiss E, Jakab G, Kranias E, Edes I 1994 Thyroid hormone induced
alterations in phospholamban protein expression. Regulatory effects on sarcoplasmic
reticulum calcium transport and myocardial relaxation. Circ Res 75: 245-251. |
| (25) |
Ojamaa K, Sabet A, Kenessey A, Shenoy R, Klein I
1999 Regulation of rat cardiac Kv1.5 gene expression by thyroid hormone
is rapid and chamber specific. Endocrinology 140: 3170-3176. |
| (26) |
Golf S, Lovstad R, Hansson V 1985 Beta-adrenoceptor
density and relative number of beta-adrenoceptor subtypes in biopsies from
human right atrial, left ventricular, and right ventricular myocard. Cardiovasc
Res 19: 636-641. |
| (27) |
Stiles G, Taylor S, Lefkowitz R 1983 Human cardiac
beta-adrenergic receptors: subtype heterogeneity delineated by direct radioligand
binding. Life Sci 33: 467-473. |
| (28) |
Dratman M, Goldman M, Crutchfield F, Gordon J 1982 Nervous system
role of iodocompounds in blood pressure regulation. Life Sci 30: 611-622. |
| (29) |
Maciel B, Gallo L, Marin Neto J, Maciel L, Martins
L 1988 Autonomic control of heart rate during dynamic exercise in human
hyperthyroidism. Clin Sci 75: 209-215. |
| (30) |
Cacciatori V, Bellavere F, Pezzarossa A, Dellera A, Gemma ML, Thomaseth
K, Castello R, Moghetti P, Muggeo M 1996 Power spectral analysis of
heart rate in hyperthyroidism. J Clin Endocrinol Metab 81: 2828-2835. |
| (31) |
Kollai B, KollaiM 1988 Reduced cardiac vagal
excitability in hyperthyroidism. Brain Res Bull 20: 785-790. |
| (32) |
Pitzalis MV, Mastropasqua F, Massari F, Ciampolillo
A, Passantino A, Ognissanti M, Mannarini A, Zanna D, Giorgino R, Rizzon
P 1998 Assessment of cardiac vagal activity in patients with hyperthyroidism.
Int J Cardiol 64: 145-151. |
| (33) |
Inukai T, Kobayashi I, Kobayashi T, Ishii A, Yamaguchi
T, Yamaguchi Y, Iwashita A, Ohshima K, Shimomura Y, Kobayashi S 1990
Parasympathetic nervous system activity in hypothyroidism determined by
RR interval variations on electrocardiogram. J Intern Med 228: 431-434. |